Carl Zeiss Meditec AG (CZMWY)
OTCMKTS
· Delayed Price · Currency is USD
71.73
+2.38 (3.43%)
May 13, 2025, 3:58 PM EDT
Carl Zeiss Meditec AG Income Statement
Financials in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2015 - 2019 |
| Revenue | 2,066 | 2,089 | 1,903 | 1,647 | 1,335 | Upgrade
|
| Revenue Growth (YoY) | -1.11% | 9.80% | 15.55% | 23.31% | -8.49% | Upgrade
|
| Cost of Revenue | 977.5 | 883.54 | 775.24 | 679.57 | 589.94 | Upgrade
|
| Gross Profit | 1,089 | 1,206 | 1,128 | 967.21 | 745.52 | Upgrade
|
| Selling, General & Admin | 558.13 | 503.12 | 438.55 | 364.77 | 349.78 | Upgrade
|
| Research & Development | 343.09 | 349.28 | 291.37 | 232.07 | 218.8 | Upgrade
|
| Other Operating Expenses | - | 4.31 | - | - | - | Upgrade
|
| Operating Expenses | 901.22 | 856.71 | 729.92 | 596.83 | 568.59 | Upgrade
|
| Operating Income | 187.41 | 349.06 | 397.68 | 370.38 | 176.93 | Upgrade
|
| Interest Expense | -29.42 | -15.25 | -9.1 | -8.58 | -27.27 | Upgrade
|
| Interest & Investment Income | 22.4 | 28.11 | 13.25 | 1.56 | 1.46 | Upgrade
|
| Earnings From Equity Investments | -3.02 | -0.89 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 11.58 | 38.2 | -48.63 | -25.1 | 4.46 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.21 | -1.85 | -2.16 | 0.09 | 0.01 | Upgrade
|
| EBT Excluding Unusual Items | 189.15 | 397.38 | 351.04 | 338.35 | 155.59 | Upgrade
|
| Merger & Restructuring Charges | -10.2 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | 0.1 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 2.45 | - | Upgrade
|
| Legal Settlements | 18.12 | - | - | - | - | Upgrade
|
| Other Unusual Items | 43.8 | 15.19 | 52.45 | -1.84 | 23.13 | Upgrade
|
| Pretax Income | 240.87 | 412.56 | 403.49 | 339.05 | 178.72 | Upgrade
|
| Income Tax Expense | 60.71 | 120.56 | 107.58 | 101.53 | 55.3 | Upgrade
|
| Earnings From Continuing Operations | 180.15 | 292.01 | 295.91 | 237.52 | 123.42 | Upgrade
|
| Minority Interest in Earnings | -1.43 | -1.61 | -2 | -1.24 | -1.04 | Upgrade
|
| Net Income | 178.73 | 290.4 | 293.91 | 236.28 | 122.39 | Upgrade
|
| Net Income to Common | 178.73 | 290.4 | 293.91 | 236.28 | 122.39 | Upgrade
|
| Net Income Growth | -38.45% | -1.20% | 24.39% | 93.06% | -23.39% | Upgrade
|
| Shares Outstanding (Basic) | 89 | 89 | 89 | 89 | 89 | Upgrade
|
| Shares Outstanding (Diluted) | 89 | 89 | 89 | 89 | 89 | Upgrade
|
| Shares Change (YoY) | -0.66% | - | - | - | - | Upgrade
|
| EPS (Basic) | 2.01 | 3.25 | 3.29 | 2.64 | 1.37 | Upgrade
|
| EPS (Diluted) | 2.01 | 3.25 | 3.29 | 2.64 | 1.37 | Upgrade
|
| EPS Growth | -38.05% | -1.20% | 24.39% | 93.06% | -23.39% | Upgrade
|
| Free Cash Flow | 160.51 | 185.21 | 145.4 | 332.54 | 149.2 | Upgrade
|
| Free Cash Flow Per Share | 1.81 | 2.07 | 1.63 | 3.72 | 1.67 | Upgrade
|
| Dividend Per Share | 0.600 | 1.100 | 1.100 | 0.900 | 0.500 | Upgrade
|
| Dividend Growth | -45.45% | - | 22.22% | 80.00% | -23.08% | Upgrade
|
| Gross Margin | 52.69% | 57.71% | 59.26% | 58.73% | 55.83% | Upgrade
|
| Operating Margin | 9.07% | 16.71% | 20.90% | 22.49% | 13.25% | Upgrade
|
| Profit Margin | 8.65% | 13.90% | 15.45% | 14.35% | 9.16% | Upgrade
|
| Free Cash Flow Margin | 7.77% | 8.87% | 7.64% | 20.19% | 11.17% | Upgrade
|
| EBITDA | 225.05 | 370.71 | 418.29 | 388.94 | 200.04 | Upgrade
|
| EBITDA Margin | 10.89% | 17.74% | 21.98% | 23.62% | 14.98% | Upgrade
|
| D&A For EBITDA | 37.64 | 21.65 | 20.61 | 18.56 | 23.11 | Upgrade
|
| EBIT | 187.41 | 349.06 | 397.68 | 370.38 | 176.93 | Upgrade
|
| EBIT Margin | 9.07% | 16.71% | 20.90% | 22.49% | 13.25% | Upgrade
|
| Effective Tax Rate | 25.21% | 29.22% | 26.66% | 29.95% | 30.94% | Upgrade
|
Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.